{"id":"https://openalex.org/W7208764787","doi":"https://doi.org/10.3389/fphar.2026.1942034","title":"The immune-related symptom web in immune checkpoint inhibitor therapy: a longitudinal clinical safety surveillance framework for immune-related adverse events","display_name":"The immune-related symptom web in immune checkpoint inhibitor therapy: a longitudinal clinical safety surveillance framework for immune-related adverse events","publication_year":2026,"publication_date":"2026-09-04","ids":{"openalex":"https://openalex.org/W7208764787","doi":"https://doi.org/10.3389/fphar.2026.1942034","pmid":"https://pubmed.ncbi.nlm.nih.gov/42761449","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13587461"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2026.1942034","doi":"https://doi.org/10.3389/fphar.2026.1942034","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1942034","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1942034/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1942034/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112383515","display_name":"Bing Li","orcid":"https://orcid.org/0000-0001-9442-8304","observed_orcids":["https://orcid.org/0000-0001-9442-8304"]},"institutions":[{"id":"https://openalex.org/I4210146008","display_name":"First Bethune Hospital of Jilin University","ror":"https://ror.org/051c4bd82","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210146008"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Bing Li","raw_affiliation_strings":["Department of Oncology, The First Bethune Hospital of Jilin University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, The First Bethune Hospital of Jilin University","institution_ids":["https://openalex.org/I4210146008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5150000274","display_name":"Haina Che","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146008","display_name":"First Bethune Hospital of Jilin University","ror":"https://ror.org/051c4bd82","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210146008"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Haina Che","raw_affiliation_strings":["Department of Oncology, The First Bethune Hospital of Jilin University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, The First Bethune Hospital of Jilin University","institution_ids":["https://openalex.org/I4210146008"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030083595","display_name":"\u5b8b\u71d5\u4e30","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146008","display_name":"First Bethune Hospital of Jilin University","ror":"https://ror.org/051c4bd82","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210146008"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Yanfeng Song","raw_affiliation_strings":["Department of Oncology, The First Bethune Hospital of Jilin University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, The First Bethune Hospital of Jilin University","institution_ids":["https://openalex.org/I4210146008"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5030083595"],"corresponding_institution_ids":["https://openalex.org/I4210146008"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":"1942034","last_page":"1942034"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.016599999740719795,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8930000066757202},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":1.0},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.8109999895095825},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.7760000228881836},{"id":"https://openalex.org/keywords/pro-ctcae","display_name":"PRO-CTCAE","score":0.8999999761581421},{"id":"https://openalex.org/keywords/electronic-patient-reported-outcomes","display_name":"electronic patient-reported outcomes","score":0.9409999847412109},{"id":"https://openalex.org/keywords/corticosteroid-tapering","display_name":"corticosteroid tapering","score":0.8159999847412109},{"id":"https://openalex.org/keywords/irae-management","display_name":"irAE management","score":0.453000009059906},{"id":"https://openalex.org/keywords/false-negative-rate","display_name":"false negative rate","score":0.4740000069141388},{"id":"https://openalex.org/keywords/alert-burden","display_name":"alert burden","score":0.46399998664855957},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-related-pneumonitis","display_name":"immune-related pneumonitis","score":0.5410000085830688},{"id":"https://openalex.org/keywords/immune-mediated-colitis","display_name":"immune-related colitis","score":0.7129999995231628}],"concepts":[{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.8210999965667725},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7742000222206116},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.7287999987602234},{"id":"https://openalex.org/C2776190711","wikidata":"https://www.wikidata.org/wiki/Q7398663","display_name":"Safety pharmacology","level":3,"score":0.5232999920845032},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4424999952316284},{"id":"https://openalex.org/C2778738651","wikidata":"https://www.wikidata.org/wiki/Q16546687","display_name":"Novelty","level":2,"score":0.41850000619888306},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.39469999074935913},{"id":"https://openalex.org/C3020000205","wikidata":"https://www.wikidata.org/wiki/Q2412849","display_name":"Narrative review","level":2,"score":0.3785000145435333},{"id":"https://openalex.org/C177212765","wikidata":"https://www.wikidata.org/wiki/Q627335","display_name":"Workflow","level":2,"score":0.37310001254081726},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.36399999260902405},{"id":"https://openalex.org/C2779328685","wikidata":"https://www.wikidata.org/wiki/Q1475557","display_name":"Patient safety","level":3,"score":0.3529999852180481},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.34700000286102295},{"id":"https://openalex.org/C22467394","wikidata":"https://www.wikidata.org/wiki/Q849359","display_name":"Multidisciplinary approach","level":2,"score":0.3431999981403351},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.33000001311302185},{"id":"https://openalex.org/C2910206359","wikidata":"https://www.wikidata.org/wiki/Q18559532","display_name":"Adverse Outcome Pathway","level":2,"score":0.31700000166893005},{"id":"https://openalex.org/C2777793932","wikidata":"https://www.wikidata.org/wiki/Q1116229","display_name":"Common Terminology Criteria for Adverse Events","level":3,"score":0.304500013589859},{"id":"https://openalex.org/C547195049","wikidata":"https://www.wikidata.org/wiki/Q1725664","display_name":"Terminology","level":2,"score":0.2863999903202057},{"id":"https://openalex.org/C2910824759","wikidata":"https://www.wikidata.org/wiki/Q6060674","display_name":"Investigational Drugs","level":3,"score":0.2815999984741211},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.27250000834465027},{"id":"https://openalex.org/C191630685","wikidata":"https://www.wikidata.org/wiki/Q4027615","display_name":"Informatics","level":2,"score":0.26420000195503235},{"id":"https://openalex.org/C3019706980","wikidata":"https://www.wikidata.org/wiki/Q445335","display_name":"Vaccine safety","level":4,"score":0.25940001010894775},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.2574999928474426},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.25279998779296875}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fphar.2026.1942034","doi":"https://doi.org/10.3389/fphar.2026.1942034","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1942034","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1942034/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13587461","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13587461/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13587461/pdf/fphar-17-1942034.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Pharmacol","raw_type":"Text"},{"id":"pmid:42761449","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42761449","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:5716daf506844ebf99fba0f804add0d2","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/5716daf506844ebf99fba0f804add0d2","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2026.1942034","doi":"https://doi.org/10.3389/fphar.2026.1942034","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1942034","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1942034/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7208764787.pdf","grobid_xml":"https://content.openalex.org/works/W7208764787.grobid-xml"},"referenced_works_count":62,"referenced_works":["https://openalex.org/W1745080294","https://openalex.org/W1842042263","https://openalex.org/W2000641721","https://openalex.org/W2113464761","https://openalex.org/W2413514895","https://openalex.org/W2569887568","https://openalex.org/W2601055810","https://openalex.org/W2620925856","https://openalex.org/W2743419024","https://openalex.org/W2754555242","https://openalex.org/W2760410509","https://openalex.org/W2776592021","https://openalex.org/W2781484625","https://openalex.org/W2781601010","https://openalex.org/W2783137027","https://openalex.org/W2789315292","https://openalex.org/W2891486030","https://openalex.org/W2893321040","https://openalex.org/W2901191795","https://openalex.org/W2903072327","https://openalex.org/W2907922784","https://openalex.org/W2919428266","https://openalex.org/W2922577842","https://openalex.org/W2942467666","https://openalex.org/W2945590213","https://openalex.org/W2948397884","https://openalex.org/W2956028371","https://openalex.org/W2987189847","https://openalex.org/W3016806376","https://openalex.org/W3023745224","https://openalex.org/W3081635153","https://openalex.org/W3137634582","https://openalex.org/W3174077356","https://openalex.org/W3184368361","https://openalex.org/W3203575974","https://openalex.org/W3205264042","https://openalex.org/W3210474759","https://openalex.org/W3213661854","https://openalex.org/W4220724635","https://openalex.org/W4220788200","https://openalex.org/W4224250553","https://openalex.org/W4281790169","https://openalex.org/W4306692674","https://openalex.org/W4362474345","https://openalex.org/W4380356348","https://openalex.org/W4385073938","https://openalex.org/W4386297160","https://openalex.org/W4387613699","https://openalex.org/W4393202208","https://openalex.org/W4400317664","https://openalex.org/W4400641244","https://openalex.org/W4403848417","https://openalex.org/W4404014883","https://openalex.org/W4404323085","https://openalex.org/W4404905754","https://openalex.org/W4405651550","https://openalex.org/W4408008566","https://openalex.org/W4408921523","https://openalex.org/W4414169193","https://openalex.org/W4417358697","https://openalex.org/W7133327903","https://openalex.org/W7161584322"],"related_works":["https://openalex.org/W4403646047","https://openalex.org/W4220906520","https://openalex.org/W2945590213","https://openalex.org/W3017346043","https://openalex.org/W4391253596","https://openalex.org/W3046013618","https://openalex.org/W7167418609","https://openalex.org/W7128162456","https://openalex.org/W7158530915","https://openalex.org/W2586675028"],"abstract_inverted_index":{"Immune":[0],"checkpoint":[1],"inhibitors":[2],"(ICIs)":[3],"produce":[4],"durable":[5],"antitumor":[6],"activity":[7],"by":[8,94,299],"releasing":[9],"inhibitory":[10],"immune":[11],"pathways,":[12],"but":[13,168],"the":[14,90,122,236,284,290],"same":[15],"pharmacology":[16],"can":[17],"disrupt":[18],"peripheral":[19],"tolerance":[20],"and":[21,33,80,89,97,112,179,189,214,221,244,254,266,304],"generate":[22],"immune-related":[23,162],"adverse":[24],"events":[25],"(irAEs)":[26],"that":[27,172],"are":[28,38,119,250],"delayed,":[29],"recurrent,":[30],"chronic,":[31],"multisystem,":[32],"clinically":[34,145],"nonspecific.":[35],"Organ-specific":[36],"guidelines":[37,96],"indispensable":[39],"once":[40],"toxicity":[41],"is":[42,152,165,274],"suspected;":[43],"however,":[44],"clinical":[45,68,282],"surveillance":[46],"commonly":[47],"begins":[48],"with":[49,116,280],"an":[50,55,109,127,202],"undifferentiated":[51],"patient":[52],"report":[53],"or":[54,143,259,295],"objective":[56],"abnormality":[57],"rather":[58,226],"than":[59,227],"a":[60,113,132,156,166,275],"confirmed":[61],"organ":[62],"diagnosis.":[63],"This":[64],"narrative":[65],"review":[66],"integrates":[67],"pharmacology,":[69],"immunobiology,":[70],"guidelines,":[71],"pharmacovigilance":[72,159],"principles,":[73],"patient-reported":[74,246],"outcome":[75,247,287],"research,":[76],"digital":[77],"monitoring":[78],"studies,":[79],"multidisciplinary":[81],"implementation":[82],"evidence.":[83],"Focused,":[84],"non-systematic":[85],"searches":[86],"of":[87,235],"PubMed/MEDLINE":[88],"Cochrane":[91],"Library,":[92],"supplemented":[93],"current":[95],"official":[98],"regulatory":[99],"sources,":[100],"were":[101],"finalized":[102],"on":[103],"18":[104],"July":[105],"2026;":[106],"representative":[107],"strategies,":[108],"evidence-provenance":[110],"map,":[111],"structured":[114],"comparison":[115],"existing":[117,224],"approaches":[118],"provided":[120],"in":[121,219],"Supplementary":[123],"Material.":[124],"We":[125],"define":[126],"individual-level":[128],"safety":[129,286],"alert":[130,206,300],"as":[131,252],"new":[133],"symptom,":[134],"functional":[135],"change,":[136,140],"laboratory":[137],"abnormality,":[138],"physiological":[139],"imaging":[141],"finding,":[142],"other":[144],"meaningful":[146],"observation":[147],"requiring":[148],"contextual":[149],"assessment.":[150],"It":[151],"not":[153,169,257],"equivalent":[154],"to":[155,208],"formal":[157],"population-level":[158],"signal.":[160],"The":[161,192,231,262,268],"symptom":[163,178],"web":[164],"symptom-centered":[167],"symptom-exclusive":[170],"model":[171],"organizes":[173],"exposure":[174],"chronology,":[175],"individual":[176],"baseline,":[177],"objective-data":[180],"combinations,":[181],"trajectories,":[182],"competing":[183],"diagnoses,":[184],"corticosteroid":[185],"tapering,":[186],"discontinuation,":[187],"rechallenge,":[188],"consequence-weighted":[190],"urgency.":[191],"Signal-Attribution-Escalation-Longitudinal":[193],"Management":[194],"(SAELM)":[195],"framework":[196],"translates":[197],"this":[198],"information":[199],"structure":[200],"into":[201],"accountable":[203],"workflow":[204],"from":[205],"capture":[207,253],"attribution,":[209],"escalation,":[210],"guideline-linked":[211],"management,":[212],"documentation,":[213],"reassessment.":[215],"Its":[216],"novelty":[217],"lies":[218],"integrating":[220],"longitudinally":[222],"organizing":[223],"components":[225],"inventing":[228],"each":[229],"component.":[230],"Patient-Reported":[232],"Outcomes":[233],"version":[234],"Common":[237],"Terminology":[238],"Criteria":[239],"for":[240,293],"Adverse":[241],"Events":[242],"(PRO-CTCAE)":[243],"electronic":[245],"(ePRO)":[248],"systems":[249],"positioned":[251],"communication":[255],"tools,":[256],"diagnostic":[258],"causal":[260],"instruments.":[261],"models":[263],"remain":[264],"conceptual":[265],"hypothesis-generating.":[267],"most":[269],"feasible":[270],"first":[271],"validation":[272],"study":[273],"prospective":[276],"multicenter":[277],"observational":[278],"cohort":[279],"independent":[281],"adjudication;":[283],"primary":[285],"should":[288],"be":[289],"false-negative":[291],"proportion":[292],"severe":[294],"organ-threatening":[296],"irAEs,":[297],"accompanied":[298],"burden,":[301],"response":[302],"time,":[303],"potentially":[305],"avoidable":[306],"urgent":[307],"escalation.":[308]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-09-05T00:00:00"}